【礼来CEO:预计礼来新减肥药将于2026年初获批】格礼来首席执行官Dave Ricks表示,公司预计其实验性减肥药最快将于2026年初获得批准。Dave Ricks在接受采访时称,礼来预计,这种名为orforglipron的药物的数据将在2025年中期之前公布。他还表示,这种药物对病人来说更方便,也更容易大规模生产。

金融界
13 Jan
礼来首席执行官Dave Ricks表示,公司预计其实验性减肥药最快将于2026年初获得批准。Dave Ricks在接受采访时称,礼来预计,这种名为orforglipron的药物的数据将在2025年中期之前公布。他还表示,这种药物对病人来说更方便,也更容易大规模生产。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10